About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Genetico
Gemabank
Nextgen
Biotechnology Developments
Betuvax
Histograft
Genotarget
Reprobank
Vitacel
21.04.2023
News
Moscow Exchange begins trading in futures and options on HSCI shares
19.04.2023
News
Children born from three parents will be rid of genetic diseases
19.04.2023
News
Moscow Exchange published the application procedure for Genetico’s IPO
13.04.2023
Press releases
RBT begins researching a new immunomodulatory drug
11.04.2023
Press releases
Genetico approved the IPO parameters
10.04.2023
News
RBT investors received an offer
06.04.2023
News
Skolkovo to reimburse business angels for up to 50% of their investments in vaccine development
1
…
22
23
24
25
26
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
